Bioactivity of Ti-6Al-4V alloy implants treated with ibandronate after the formation of the nanotube TiO2 layer.
Nanostructure surface of titanium implants treated with anodic oxidation, heat, and bisphosphonates, has been introduced to improve osseointegration of the implants. However, no information could be found about the efficiency of these approaches on Ti-6Al-4V alloy surfaces. This study examined the drug loading capacity of anodized nanotubular Ti-6Al-4V alloy surfaces in vitro as well as the bone response to surface immobilized bisphosphonates (BPs) on anodized nanotubular Ti-6Al-4V alloy surface in tibiae of rats. Ti-6Al-4V alloy titanium was divided into two groups: (1) control group (nontreated); (2) test group (anodized, heat-, and bisphosphonate-treated group). In vitro, amount of the drug released from the both groups' specimens was examined; all samples were 1 × 2 cm in size. In vivo, the 10 implants were placed inside of tibias of five rats. After 4 weeks, the bone response of the implants was evaluated using a removal torque test, and measuring bone contact and bone area. In addition, the surfaces of the extracted implants were observed by FE-SEM and EDS. In vitro, the drug loading capacity of the Ti-6Al-4V alloy surfaces was enhanced by anodizing surface modification. The values of the removal torque, bone contact, and bone area were significantly higher in the test group (p < 0.05). Furthermore, according to the EDS analysis, the amounts of Ca and P on the surface of the extracted implants were higher in the test group. Within the limits of this experiment, results of this research demonstrated that bisphosphonate-treated Ti-6Al-4V alloy implants with nanotubular surfaces have positive effects in bone-to-implant contact.
Department of Periodontology, School of Dentistry, Institute of Oral Bioscience and Brain Korea 21, Chonbuk National University, Jeonju, South Korea.
So-Hee
SH
Moon
Seung-Jae
SJ
Lee
Il-Song
IS
Park
Min-Ho
MH
Lee
Yun-Jo
YJ
Soh
Tae-Sung
TS
Bae
Hyung-Seop
HS
Kim
D000497:Alloys; D000818:Animals; D050071:Bone Density Conservation Agents / Q000737:chemistry / Q000494:pharmacology; D018786:Bone Substitutes / Q000737:chemistry / Q000494:pharmacology; D004164:Diphosphonates / Q000737:chemistry / Q000494:pharmacology; D000077557:Ibandronic Acid; D008297:Male; D008422:Materials Testing; D043942:Nanotubes / Q000737:chemistry*; D016062:Porosity; D051381:Rats; D017208:Rats, Wistar; D013978:Tibial Fractures / Q000473:pathology / Q000628:therapy*; D014025:Titanium / Q000737:chemistry / Q000494:pharmacology
D000497:Alloys; D050071:Bone Density Conservation Agents; D018786:Bone Substitutes; D004164:Diphosphonates; C031462:titanium alloy (TiAl6V4); C009495:titanium dioxide; D014025:Titanium; D000077557:Ibandronic Acid